A Simple Method for Predicting Modes of Actions of Antitumor Agents
スポンサーリンク
概要
- 論文の詳細を見る
Modes of actions of antitumor agents can be predicted by comparison of antitumor activities against L1210 cells in the presence and absence of some nucleosides. 1) Deoxyribonucleic acid (DNA) inhibitors were mainly antagonized by thymidine. 2) Both DNA and ribonucleic acid (RNA) inhibitors were mainly antagonized by adenosine and uridine. 3) Uridine antagonized the activities of an RNA inhibitor. 4) Nonc of these nucleosides tested antagonized the antitumor activities of an inhibitor of protein synthesis. 5) A mitotic inhibitor was weakly antagonized by thymidine, adenosine and uridine. This method is useful for approximating the modes of actions of antitumor agents without using radioactive precursors.
- 社団法人日本薬学会の論文
著者
-
Hoshi Akio
Pharmacology Division National Cancer Center Research Institute
-
FUKUYASU Harumi
Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd.
-
Fukuyasu H
Meiji Seika Kaisha Ltd. Yokohama Jpn
-
Fukuyasu Harumi
Pharmaceutical Development Laboratories Meiji Seika Kaisha Ltd. : Central Research Laboratories Meij
-
NAKAJIMA Shokichi
Pharmaceutical Development Laboratories, Meiji Seika Kaisha, Ltd.
-
Hoshi Akio
Pharmaceutical Development Laboratories Meiji Seika Kaisha Ltd. : Central Research Laboratories Meij
-
YOSHIDA MITSUZI
Pharmacology Division, National Cancer Center Research Institute
-
SATO Yasumi
Pharmaceutical Development Laboratories, Meiji Seika Kaisha, Ltd.
-
KAZUNO Yuzo
Pharmaceutical Development Laboratories, Meiji Seika Kaisha, Ltd.
-
Kazuno Yuzo
Pharmaceutical Development Laboratories Meiji Seika Kaisha Ltd. : Central Research Laboratories Meij
-
Sato Yasumi
Pharmaceutical Development Laboratories Meiji Seika Kaisha Ltd. : Central Research Laboratories Meij
-
Yoshida M
Pharmaceutical Development Laboratories Meiji Seika Kaisha Ltd. : Central Research Laboratories Meij
-
Yoshida Mitsuzi
Pharmacology Division National Cancer Center Research Institute
-
Nakajima S
Meiji Seika Kaisha Ltd. Kawasaki‐shi Jpn
-
Nakajima Shokichi
Pharmaceutical Development Laboratories Meiji Seika Kaisha Ltd.
-
YOSHIDA Mitsuzi
Pharmaceutical Development Laboratories, Meiji Seika Kaisha, Ltd. : Central Research Laboratories, Meiji Seika Kaisha, Ltd. : National Cancer Center Research Institute.
関連論文
- Synthesis and antimetastatic activity of 6-Trichloracetamido and 6-Guanidino Analogues of Siastatin B
- Inhibition of Pulmonary Metastases and Tumor Cell Invasion in Experimental Tumors by Sodium _D-Glucaro-δ-lactam (ND2001)
- ANTITUMOR ACTIVITY OF 1-ACYLOXYMETHYL DERIVATIVES OF 5-FLUOROURACIL AGAINST L1210 LEUKEMIA
- ANTITUMOR ACTIVITY OF 1-ALKOXYCARBONYLALKYLCAR-BAMOYL-5-FLUOROURACIL DERIVATIVES BY ORAL ADMINISTRATION
- Production and Some Properties of Monoclonal Antibodies against Serotype Strains of Pseudomonas aeruginosa
- ANTITUMOR ACTIVITY OF DERIVATIVES OF NEPLANOCIN A IN VIVO AND IN VITRO
- ISOLATION AND CHARACTERIZATION OF THE MURINE LYMPHOMA L5178Y CELL LINE HIGHLY RESISTANT TO 5-FLUOROURACIL
- THE DIFFERENCE IN MECHANISM OF ACTION OF 5-FLUOROURACIL AND ITS NUCLEOSIDES IN L5178Y CELLS
- A Simple Method for Predicting Modes of Actions of Antitumor Agents
- POTENTIATION OF ANTITUMOR ACTIVITY OF 5-FLUORO-2', DEOXYURIDINE BY GUANOSINE-5'-MONOPHOSPHATE
- ANTITUMOR ACTIVITY OF ALKYLESTERS OF 5-FLUORO-2'-DEOXYURIDINE 5'-MONOPHOSPHATE (FDUMP) AGAINST MURINE LYMPHOMA L5178Y RESISTANT TO 5-FLUORO-2'-DEOXYURIDINE
- IMPROVEMENT OF THERAPEUTIC EFFECT OF 5-FLUOROURACIL BY OROTIC ACID
- EFFECT OF PYRIMIDINES, PURINES AND THEIR NUCLEOSIDES ON ANTITUMOR ACTIVITY OF 5-FLUOROURACIL AGAINST L-1210 LEUKEMIA
- EXCRETION OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL IN URINE OF MICE
- ANTITUMOR ACTIVITY OF METABOLITES OF 1-HEXYLCAR-BAMOYL-5-FLUOROURACIL AND RELATED COMPOUNDS AGAINST L1210 LEUKEMIA IN VIVO AND L5178Y LYMPHOMA CELLS IN VITRO
- RELATIONSHIP BETWEEN CHEMICAL STRUCTURE AND ANTITUMOR ACTIVITY OF WITHAFERIN A ANALOGUES
- DISTRIBUTION OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL AND 5-FLUOROURACIL BY ORAL ADMINISTRATION IN MICE
- ANTITUMOR ACTIVITY OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL IN LEWIS LUNG CARCINOMA AND B16 MELANOMA
- U1B3.3 monoclonal antibody recognizes a precursor of NK1.1+ cytotoxic T cells generated by interleukin-2
- Synergistic inhibition of the growth of adenocarcinoma 755 by the combination of interleukin-2 and interferon-.BETA..